Growing community of inventors

Pulheim, Germany

Dirk Meurer

Average Co-Inventor Count = 12.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 30

Dirk MeurerKarl-Heinz Schlemmer (5 patents)Dirk MeurerVolkhart Min-Jian Li (5 patents)Dirk MeurerUlrich Rosentreter (5 patents)Dirk MeurerLars Bärfacker (5 patents)Dirk MeurerMary F Fitzgerald (5 patents)Dirk MeurerLeila Telan (5 patents)Dirk MeurerHeike Gielen-Haertwig (5 patents)Dirk MeurerBarbara Albrecht (5 patents)Dirk MeurerSwen Allerheiligen (5 patents)Dirk MeurerKevin Nash (5 patents)Dirk MeurerJörg Keldenich (4 patents)Dirk MeurerJörg Keldenieh (1 patent)Dirk MeurerDirk Meurer (5 patents)Karl-Heinz SchlemmerKarl-Heinz Schlemmer (120 patents)Volkhart Min-Jian LiVolkhart Min-Jian Li (55 patents)Ulrich RosentreterUlrich Rosentreter (48 patents)Lars BärfackerLars Bärfacker (37 patents)Mary F FitzgeraldMary F Fitzgerald (18 patents)Leila TelanLeila Telan (15 patents)Heike Gielen-HaertwigHeike Gielen-Haertwig (14 patents)Barbara AlbrechtBarbara Albrecht (13 patents)Swen AllerheiligenSwen Allerheiligen (12 patents)Kevin NashKevin Nash (7 patents)Jörg KeldenichJörg Keldenich (41 patents)Jörg KeldeniehJörg Keldenieh (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bayer Healthcare Aktiengesellschaft (3 from 76 patents)

2. Bayer Pharma Aktiengesellschaft (1 from 378 patents)

3. Bayer Schering Pharma Ag (1 from 192 patents)


5 patents:

1. 8173665 - I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use

2. 7691854 - Dihydropyridine derivatives for use as human neutrophil elastase inhibitors

3. 7687510 - Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes

4. 7566723 - 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use

5. 7230017 - Dihydropyridinone derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…